Profile

Publications

Bauer LA, Black DJ, Lill JS, Vancomycin dosing in morbidly obese patients., European Journal of Clinical Pharmacology, 54(8), 621-5, October 1998
Bauer L A, Schumock G, Horn J, Opheim K, Verapamil inhibits ethanol elimination and prolongs the perception of intoxication., Clinical Pharmacology and Therapeutics, 52(1), 6-10, July 1992
Reiss W G, Bauer L A, Horn J R, Zierler B K, Easterling T R, Strandness D E Jr, The effects of oral nifedipine on hepatic blood flow in humans., Clinical Pharmacology and Therapeutics, 50(4), 379-84, October 1991
O'Sullivan T A, Bauer L A, Horn J R, Zierler B K, Strandness D E Jr, Williams-Warren J, Smith A L, Unadkat J D, Disposition of drugs in cystic fibrosis. II. Hepatic blood flow., Clinical Pharmacology and Therapeutics, 50(4), 450-5, October 1991
Bauer L A, McDonnell N, Horn J R, Zierler B, Opheim K, Strandness D E Jr, Single and multiple doses of oral cimetidine do not change liver blood flow in humans., Clinical Pharmacology and Therapeutics, 48(2), 195-200, August 1990
Bauer L A, Black D, Gensler A, Procainamide-cimetidine drug interaction in elderly male patients., Journal of The American Geriatrics Society, 38(4), 467-9, April 1990
Bauer L A, Murray K, Horn J R, Opheim K, Olsen J, Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics., European Journal of Clinical Pharmacology, 37(3), 257-60, 1989
Bauer LA, Horn JR, Pettit H: Using mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations. Ther Drug Monitor 18: 46-52, 1996
Bauer LA, O'Sullivan T, Horn JR, Lau H, Chan K, Strandness DE, Carrithers R: Diclofenac kinetics in patients with liver disease. Poster presentation at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, 1996
Bauer LA: Simulations of levothyroxine bioavailability using a single-dose study protocol. Am J Ther 2: 1-3, 1995
Bauer LA, Horn JR, Pettit H: Using mixed-effect modeling to detect and evaluate drug interactions in patients: digoxin-quinidine and digoxin-verapamil drug combinations. Poster presentation at the Annual Meeting of the American College of Clinical Pharmacy, 1995
Bauer LA, O'Sullivan T, Horn JR, Lau H, Chan K, Strandness DE, Carithers R: Diclofenac metabolite kinetics in chronic active hepatitis or alcoholic cirrhosis. Poster presentation at the Annual Meeting of the American Society for Clinical Pharmacology andTherapeutics, 1995
Bauer LA, O'Sullivan T, Reiss WG, Horn JR, Opheim K, Strandness DE, Carithers RL: Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis. Br J Clin Pharmacol37: 375-81, 1994
Reiss WG, Bauer LA, Horn JR, Zierler BK, Easterling TR, Strandness DE: The acute effects of sublingual nitroglycerin on hepatic blood flow in healthy volunteers. J Clin Pharmacol, 34: 912-8, 1994
Bauer LA: Development of a unique model to determine the biopharmaceutics of levothyroxine in humans. Invited presentation to the Endocrine & Anti-inflammatory Research Group of Boots Pharmaceuticals, 1994
Bauer LA: Pharmacokinetics of antipyrine and diclofenac in normal subjects and liver disease patient--preliminary data. Invited presentation to the Bioanalytics & Pharmacokinetics Research Group of Ciba-Geigy, 1994
Bauer LA, O'Sullivan T, Reiss WG, Horn J, Opheim K, Strandness DE, Carithers R: Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearances--correlations in patients with chronic active hepatitis and alcoholic cirrhosis. Posterpresentation at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, 1994
Bauer LA: Chapter 2--Pharmacodynamic drug interactions. In Drug Interactions--7th edition (Hansten PD and Horn JR, eds.), Lea & Febiger, Philadelphia, 1993. (Also appeared in 6th edition)
Pettit HE, Bauer LA, Horn JR: Digoxin-quinidine drug interaction--a population-based model. Poster presentation at the Midyear Clinical Meeting of the American Society of Hospital Pharmacists, 1993
Bauer LA, O'Sullivan T, Reiss WG, Horn JR, Opheim K, Strandness DE, Carithers R: Antipyrine metabolite formation clearances in patients with chronic active hepatitis and alcoholic cirrhosis. Poster presentation at the Annual Meeting of the American College of Clinical Pharmacy, 1993
Bauer LA, O'Sullivan T, Reiss W, Horn J, Opheim K, Strandness DE, Carithers R: Effect of chronic active hepatitis and alcoholic cirrhosis on liver blood flow and antipyrine pharmacokinetics. Poster presentation at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, 1993
Maxon MS, Bauer LA, Horn JR, Strandness DE: Single dose study of the effects on hepatic blood flow of the drug interaction between verapamil and metoprolol. Poster presentation at the Midyear Clinical Meeting of the American Society of Hospital Pharmacists, 1992
Zierler BK, Kirkman TR, Kraiss LW, Reiss WG, Horn JR, Bauer LA, Clowes AW, Kohler TR: Accuracy of duplex scanning for measurement of arterial volume flow. Platform presentation at the Annual Meeting of the Western Vascular Society, 1992
Bauer LA: Aminoglycoside dosing and nephrotoxicity. Invited presentation at Valley Medical Center Medical Grand Rounds, 1992
O'Sullivan TA, Bauer LA, Reiss WG, Horn JR, Strandness DE, Carithers RL: Diclofenac does not change hepatic blood flow in patients with hepatitis. Poster presentation at the Annual Meeting of the American College of Clinical Pharmacy, 1992
Bauer LA: Individualization of drug therapy: Clinical pharmacokinetics and pharmacodynamics. In Pharmacotherapy: A Pathophysiologic Approach, Third edition (Posey M, ed.), Elsevier, New York, in press. (Updated, also appeared in second edition)

Larry Bauer

Mailing Address

Contact Information

Keywords

COS Keywords:

Publications

Profile Details